Minirin and Effexor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Minirin (desmopressin acetate) and Effexor (venlafaxine hydrochloride). Common drug interactions include autoimmune hepatitis among females and aggression among males.

The phase IV clinical study analyzes what interactions people have when they take Minirin and Effexor. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Minirin?

Minirin has active ingredients of desmopressin acetate. It is often used in diabetes insipidus. eHealthMe is studying from 1,364 Minirin users. Check the latest studies of Minirin.

What is Effexor?

Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 99,493 Effexor users. Check the latest studies of Effexor.



On Jul, 25, 2026

19 people who take Minirin and Effexor together, and have interactions are studied.

Minirin and Effexor drug interactions.

What are the common drug interactions of Minirin and Effexor, by gender? *:

female:

  1. Autoimmune hepatitis
  2. Blood bilirubin increased
  3. Gamma-glutamyltransferase increased
  4. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  5. Cytolytic hepatitis (dissolution or destruction of a liver cell)
  6. Hepatic enzyme increased
  7. Tonic convulsion (the person will quickly lose consciousness and the skeletal muscles will suddenly tense, often causing the extremities to be pulled towards the body or rigidly pushed away from it)
  8. Alanine aminotransferase increased
  9. Aspartate aminotransferase increased
  10. Asthenia (weakness)

male:

  1. Aggression
  2. Alanine aminotransferase increased
  3. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  4. Infection
  5. Myalgia (muscle pain)
  6. Diabetic foot
  7. Dyspnoea (difficult or laboured respiration)
  8. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  9. Proteinuria (presence of protein in the urine)
  10. Pulmonary embolism (blockage of the main artery of the lung)

What are the common drug interactions of Minirin and Effexor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Diabetic foot
  2. Dyspnoea (difficult or laboured respiration)
  3. Proteinuria (presence of protein in the urine)
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Renal failure (kidney dysfunction)
  6. Vasculitis (inflammation of a blood vessel or blood vessels)

30-39:

n/a

40-49:

  1. Chills (felling of cold)
  2. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  3. Confusional state
  4. Cytolytic hepatitis (dissolution or destruction of a liver cell)
  5. Diarrhoea
  6. Disturbance in attention
  7. Hepatic enzyme increased
  8. Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
  9. Pyrexia (fever)
  10. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

50-59:

n/a

60+:

  1. Tonic convulsion (the person will quickly lose consciousness and the skeletal muscles will suddenly tense, often causing the extremities to be pulled towards the body or rigidly pushed away from it)
  2. Arthropathy
  3. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

What are the existing conditions these people have? *

  1. Primary Hypothyroidism (failure of the thyroid gland to produce or release thyroid hormones into the bloodstream): 5 people, 26.32%
  2. Essential Hypertension (primary hypertension): 4 people, 21.05%
  3. Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 4 people, 21.05%
  4. Hypogonadism Male (male testes produce little or no sex hormone): 4 people, 21.05%
  5. Blood Antidiuretic Hormone Decreased: 4 people, 21.05%
  6. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 21.05%
  7. Blood Thyroid Stimulating Hormone Decreased: 4 people, 21.05%
  8. Blood Luteinising Hormone Decreased: 4 people, 21.05%
  9. Blood Follicle Stimulating Hormone Decreased: 4 people, 21.05%
  10. Blood Corticotrophin Decreased: 4 people, 21.05%

* Approximation only. Some reports may have incomplete information.

Do you take Minirin and Effexor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Minirin and Effexor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Minirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Effexor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Minirin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Effexor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on desmopressin acetate and venlafaxine hydrochloride (the active ingredients of Minirin and Effexor, respectively), and Minirin and Effexor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: